r.sobczak
TL2 Moderator · Essen
Contributes reviews on supplier material. Based in Essen.
Joined 14 July 2025 · last posted 10d
98 posts, newest first. Showing up to 150.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #110 · Devices › Syringes & needles · 17 Jul 2026 · 9 likes Coming back to post #108, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #86 · Practice › Storage & stability · 11 Jul 2026 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Prescription requirements and telehealth models — a second dataset Replied, post #86 · Sourcing › Regulatory · 30 Jun 2026 · 6 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 21 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Official shortage notices and what they authorise Replied, post #119 · Access › Shortages · 21 Jun 2026 · 4 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Naming conventions for research peptides and the confusion they cause Replied, post #18 · Compounds › Other compounds · 20 Jun 2026 · 0 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #4 · Evidence › Preprints · 19 Jun 2026 · 3 likes This follows post #2 rather than contradicting it. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge.…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #49 · Analytics › Method validation · 10 Jun 2026 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #122 · Practice › Interactions · 9 Jun 2026 · 18 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #43 · Sourcing › Red flags · 4 Jun 2026 · 33 likes Worth separating two things that post #39 runs together. Patterns that reliably precede a problem: underdosing (less active material than stated, documented by…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #42 · Compounds › Semaglutide · 28 May 2026 · 9 likes Worth separating two things that post #38 runs together. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #24 · Pharmacology › Formulation chemistry · 19 May 2026 · 12 likes Preservatives: solutions for multi-dose vials contain preservatives (benzyl alcohol, phenol, or others) to inhibit microbial growth after the vial has been entered.…
-
An 18-month record including the parts that went badly Replied, post #15 · Outcomes › Progress reports · 13 May 2026 · 0 likes This follows post #12 rather than contradicting it. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the…
-
Spreadsheets: an appreciation — what changed since Replied, post #41 · Lounge › Off topic · 13 May 2026 · 17 likes Worth separating two things that post #37 runs together. Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has…
-
Shakes versus food: a pragmatic assessment Replied, post #9 · Nutrition & Training › Protein & intake · 11 May 2026 · 0 likes On post #5 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
-
Blind submission and why it changes minds — the long version Replied, post #54 · Sourcing › Independent verification · 3 May 2026 · 8 likes post #53 is right about the mechanism and I think understates the practical bit. Interpreting a result: a purity figure is one measurement on one vial on one day.…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #35 · Practice › Interactions · 30 Apr 2026 · 3 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
[2026 update] What a purity-only report leaves out Replied, post #100 · Sourcing › Independent verification · 22 Apr 2026 · 29 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
[2026 update] Buffers, pH and why a formulation is a formulation Replied, post #3 · Pharmacology › Formulation chemistry · 17 Apr 2026 · 2 likes This follows post #2 rather than contradicting it. Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause discomfort…
-
Choosing which test to pay for, given a fixed budget Replied, post #68 · Sourcing › Independent verification · 13 Apr 2026 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #14 · Devices › Syringes & needles · 13 Apr 2026 · 1 like Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #52 · Data & Tools › Calculators · 21 Mar 2026 · 6 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Second pass at: Submitting a sample: the process end to end Replied, post #15 · Sourcing › Independent verification · 21 Mar 2026 · 0 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #54 · Start Here › Welcome · 16 Mar 2026 · 6 likes Coming back to post #52, because the follow-up matters more than the original answer. There is no stupid-questions rule and no penalty for asking badly. The response to…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #16 · Analytics › Impurities & related substances · 14 Mar 2026 · 0 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Clearance pathways and what renal impairment changes Replied, post #10 · Pharmacology › Pharmacokinetics · 10 Mar 2026 · 1 like post #9 answers the question as asked. The question underneath it is different. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #18 · Compounds › Secretagogues & GH axis · 8 Mar 2026 · 20 likes Picking up post #15: that is the part I would want checked first. Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #47 · Research Methods › Statistics · 7 Mar 2026 · 0 likes P-values and significance: p
-
Research-use-only labelling: what it means and what it does not Replied, post #108 · Sourcing › Regulatory · 25 Feb 2026 · 25 likes Picking up post #105: that is the part I would want checked first. Approval versus licensing: a compound can be approved for a specific indication in one country and…
-
Second pass at: Identical chromatograms across two different lots Replied, post #10 · Sourcing › Red flags · 16 Feb 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Regional warehouse stock versus direct despatch Started this topic · Sourcing › Logistics · 13 Feb 2026 · 11 likes Regional warehouse stock versus direct despatch Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #36 · Practice › Storage & stability · 8 Feb 2026 · 0 likes Picking up post #33: that is the part I would want checked first. Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for…
-
Dead volume across syringe and needle combinations Replied, post #68 · Devices › Syringes & needles · 8 Feb 2026 · 27 likes Coming back to post #66, because the follow-up matters more than the original answer. Insulin syringe graduations: U-100 syringes are marked in units where 100 units =…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #79 · Clinical › Special populations · 25 Jan 2026 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: PIONEER 6 as a safety trial Replied, post #14 · Evidence › Journal club · 16 Jan 2026 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #4 · Compounds › Repair & healing peptides · 9 Jan 2026 · 9 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
What to include when your question involves a chromatogram Replied, post #11 · Start Here › How to Ask · 31 Dec 2025 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #32 · Compounds › Retatrutide · 24 Dec 2025 · 30 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #9 · Documentation › Wiki requests · 23 Dec 2025 · 1 like On post #5 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #35 · Compounds › Other compounds · 15 Dec 2025 · 11 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Reading an interaction checker output critically Replied, post #43 · Practice › Interactions · 14 Nov 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #94 · Devices › Cold chain · 23 Oct 2025 · 13 likes I read post #92 twice before replying, because I had assumed the opposite. Temperature logging: devices that record temperature over time let you confirm cold chain was…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #45 · Compounds › Tirzepatide · 21 Oct 2025 · 0 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #117 · Practice › Administration · 18 Oct 2025 · 14 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A preprint whose numbers changed substantially at publication Replied, post #54 · Evidence › Preprints · 15 Sep 2025 · 0 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #78 · Data & Tools › Datasets · 9 Sep 2025 · 17 likes Coming back to post #76, because the follow-up matters more than the original answer. Reproducibility: if sharing data, include enough context (compound, dose,…
-
Temperature loggers worth the money Replied, post #26 · Devices › Cold chain · 4 Sep 2025 · 6 likes Picking up post #23: that is the part I would want checked first. Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light…
-
Research-use-only labelling: what it means and what it does not Replied, post #29 · Sourcing › Regulatory · 3 Sep 2025 · 27 likes This follows post #26 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Column chemistry choices for a 40-residue peptide Replied, post #20 · Analytics › HPLC & UHPLC · 24 Aug 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
An emergency department visit, described afterwards Replied, post #55 · Safety › Adverse events · 17 Aug 2025 · 28 likes Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation) warrant urgent evaluation. Severe dehydration during weight loss is a…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #45 · Compounds › Retatrutide · 12 Aug 2025 · 22 likes post #44 answers the question as asked. The question underneath it is different. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #9 · Data & Tools › Datasets · 11 Aug 2025 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #5 · Evidence › Journal club · 8 Aug 2025 · 32 likes post #4 answers the question as asked. The question underneath it is different. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
How to research a compound with no human data without deceiving yourself Replied, post #72 · Compounds › Other compounds · 2 Aug 2025 · 5 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
A field-by-field walk through a certificate of analysis Replied, post #64 · Analytics › COA interpretation · 16 Jul 2025 · 4 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #26 · Practice › Reconstitution · 16 Jul 2025 · 5 likes Worth separating two things that post #22 runs together. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #158 · Evidence › Journal club · 14 Jul 2025 · 5 likes post #157 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #46 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2025 · 1 like The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #21 · Data & Tools › Datasets · 1 Jul 2025 · 19 likes Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
-
System suitability injections: if they failed, the run did not happen Replied, post #11 · Analytics › HPLC & UHPLC · 1 Jul 2025 · 5 likes I read post #9 twice before replying, because I had assumed the opposite. This is why a purity figure without the underlying chromatogram is weaker evidence than it…
-
EU-wide position versus national implementation Replied, post #14 · Regional › European Union · 29 Jun 2025 · 4 likes Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
-
Comparing my trajectory with the trial curves, carefully Replied, post #13 · Outcomes › Progress reports · 12 Jun 2025 · 21 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #43 · Regional › UK & Ireland · 6 Jun 2025 · 20 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Antibiotics and a course of something with delayed emptying Replied, post #37 · Practice › Interactions · 9 May 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A supplier that answers analytical questions with restated claims Replied, post #64 · Sourcing › Red flags · 25 Apr 2025 · 17 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Adjudicated events and why the definition matters — the long version Replied, post #116 · Evidence › Trials · 24 Apr 2025 · 1 like Picking up post #113: that is the part I would want checked first. The estimand: what the trial set out to estimate. Two trials can be identical in structure but…
-
Requesting a page: what makes a good request Replied, post #55 · Documentation › Wiki requests · 13 Apr 2025 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A certificate with no method stated: what can you conclude? Replied, post #41 · Analytics › COA interpretation · 7 Apr 2025 · 7 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Preservatives: function, testing, and limits Replied, post #28 · Pharmacology › Formulation chemistry · 5 Apr 2025 · 33 likes post #27 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #53 · Sourcing › Vendor reports · 4 Apr 2025 · 4 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #77 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 21 likes post #76 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
A certificate with no method stated: what can you conclude? Replied, post #10 · Analytics › COA interpretation · 30 Mar 2025 · 3 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Maintainer handover: how it works Replied, post #58 · Meta › Wiki maintenance · 17 Mar 2025 · 11 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #4 · Evidence › Journal club · 15 Mar 2025 · 21 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #104 · Pharmacology › Receptor biology · 15 Mar 2025 · 0 likes This follows post #101 rather than contradicting it. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #81 · Analytics › COA interpretation · 14 Mar 2025 · 3 likes Picking up post #78: that is the part I would want checked first. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #28 · Practice › Interactions · 11 Mar 2025 · 0 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Assessing a warm arrival: the decision process Replied, post #11 · Sourcing › Logistics · 8 Mar 2025 · 32 likes Coming back to post #9, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #135 · Sourcing › Regulatory · 5 Mar 2025 · 3 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #7 · marked as the solution · Clinical › Bloodwork · 27 Feb 2025 · 11 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Validating a method you did not develop — does this still hold? Replied, post #29 · Analytics › Method validation · 21 Feb 2025 · 32 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Canadian access and provincial variation Replied, post #47 · Regional › North America · 2 Feb 2025 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #96 · Compounds › Semaglutide · 31 Jan 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #25 · Practice › Interactions · 28 Jan 2025 · 25 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
A page that has drifted out of date and needs a maintainer Replied, post #42 · Documentation › Wiki requests · 21 Dec 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #14 · Evidence › Journal club · 16 Dec 2024 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Transit times by route, from a logged dataset — the long version Replied, post #35 · Sourcing › Logistics · 3 Dec 2024 · 0 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #12 · Practice › Dosing & titration · 29 Nov 2024 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Time to steady state after a dose increase Replied, post #132 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes I read post #130 twice before replying, because I had assumed the opposite. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #4 · Practice › Reconstitution · 3 Nov 2024 · 1 like Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #18 · Clinical › Comorbidities · 11 Oct 2024 · 1 like post #17 answers the question as asked. The question underneath it is different. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with…
-
Gallbladder disease risk with rapid weight loss Replied, post #16 · Clinical › Comorbidities · 5 Oct 2024 · 0 likes This follows post #13 rather than contradicting it. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied…
-
Correlation in a self-tracked dataset: what it can support Replied, post #51 · Research Methods › Statistics · 22 Aug 2024 · 0 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #14 · Analytics › Method validation · 11 Aug 2024 · 0 likes Coming back to post #12, because the follow-up matters more than the original answer. Precision and repeatability: within-run and between-run variability of the method.…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #15 · Analytics › COA interpretation · 8 Aug 2024 · 2 likes This follows post #12 rather than contradicting it. When a document puts the specification in the result column, it has told you the release criterion, not the…
-
How this community labels and discusses unrefereed work Replied, post #94 · Evidence › Preprints · 18 Jul 2024 · 18 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #6 · marked as the solution · Analytics › COA interpretation · 14 Jul 2024 · 7 likes post #5 is right about the mechanism and I think understates the practical bit. Reading old certificates: if a certificate is dated years ago, the lot it describes…
-
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #3 · Practice › Administration · 25 Jun 2024 · 16 likes Picking up post #2: that is the part I would want checked first. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always…